Year All20242023202220212020 Aug 07, 2024 Fractyl Health to Report Second Quarter 2024 Financial Results and Provide Business Updates on August 14, 2024 Read More Jul 30, 2024 Fractyl Health Receives FDA Breakthrough Device Designation for Revita in Weight Maintenance for People with Obesity Who Discontinue GLP-1 Based Drugs Read More Jun 25, 2024 Fractyl Health to Present at Piper Sandler 2nd Annual Virtual Obesity Day Read More Jun 24, 2024 Fractyl Health Announces Advancement in Weight Maintenance Pipeline and Business Updates Read More Jun 23, 2024 Fractyl Health Presents New Preclinical Data on Sustained Weight Maintenance and Improved Body Composition from its Rejuva® Single-Administration GLP-1 Pancreatic Gene Therapy in President’s Select Oral Presentation at the American Diabetes Association’s 84th Scientific Sessions Read More May 29, 2024 Fractyl Health to Present New Preclinical Obesity Data from Rejuva® Platform at the American Diabetes Association’s 84th Scientific Sessions Read More May 20, 2024 Fractyl Health Presents Compelling Preclinical Data from Single-Administration GLP-1 Pancreatic Gene Therapy Rejuva® at Digestive Disease Week 2024 Read More May 13, 2024 Fractyl Health Reports First Quarter 2024 Financial Results and Provides Business Updates Read More
Aug 07, 2024 Fractyl Health to Report Second Quarter 2024 Financial Results and Provide Business Updates on August 14, 2024
Jul 30, 2024 Fractyl Health Receives FDA Breakthrough Device Designation for Revita in Weight Maintenance for People with Obesity Who Discontinue GLP-1 Based Drugs
Jun 24, 2024 Fractyl Health Announces Advancement in Weight Maintenance Pipeline and Business Updates
Jun 23, 2024 Fractyl Health Presents New Preclinical Data on Sustained Weight Maintenance and Improved Body Composition from its Rejuva® Single-Administration GLP-1 Pancreatic Gene Therapy in President’s Select Oral Presentation at the American Diabetes Association’s 84th Scientific Sessions
May 29, 2024 Fractyl Health to Present New Preclinical Obesity Data from Rejuva® Platform at the American Diabetes Association’s 84th Scientific Sessions
May 20, 2024 Fractyl Health Presents Compelling Preclinical Data from Single-Administration GLP-1 Pancreatic Gene Therapy Rejuva® at Digestive Disease Week 2024
May 13, 2024 Fractyl Health Reports First Quarter 2024 Financial Results and Provides Business Updates